Target intelligence / Profile preview

Myotonic dystrophy protein kinase 3' untranslated region CUG-repeat RNA foci (DMPK CUG-repeat RNA foci) (DMPK CUG-repeat RNA foci)

Target
DMPK CUG-repeat RNA foci
Molecular classification
RNA, RNA aggregate, Non-coding RNA element
01

Overview

Mutant DMPK 3'UTR CUG-repeat RNA foci are pathogenic nuclear aggregates formed by the transcription of the DMPK gene containing expanded CTG repeats (Thornton, 2014; PubMed: 25037086). In Myotonic Dystrophy Type 1 (DM1), these expanded CUG repeats in the mRNA's 3' untranslated region (UTR) fold into stable hairpin structures that accumulate in the nucleus (Miller et al., 2000; PubMed: 10944116). These foci act as a molecular sink, sequestering essential RNA-binding proteins, most notably the Muscleblind-like (MBNL) family, while causing the upregulation of CELF1 (Nature Reviews Disease Primers, 2021; DOI: 10.1038/s41572-020-00232-7). This protein imbalance leads to widespread spliceopathies, where fetal isoforms of various proteins are incorrectly expressed in adult tissues, resulting in the multi-systemic symptoms of DM1, such as myotonia, muscle wasting, and cardiac conduction defects (JCI, 2018; DOI: 10.1172/JCI123854). Therapeutic strategies targeting these foci include antibody-oligonucleotide conjugates (AOCs) like delpacibart zotadirsen and antisense oligonucleotides (ASOs) designed to either degrade the mutant RNA or displace sequestered proteins to restore normal cellular function (Avidity Biosciences, 2024; Dyne Therapeutics, 2024).

Other names
Mutant DMPK RNACUG-expanded RNADM1 RNA fociToxic CUG RNADMPK (CUG)n RNA
02

Mechanism of action

RNase H-mediated RNA degradation, RNA interference (RNAi), and steric hindrance to prevent protein sequestration (Nature Reviews Disease Primers, 2021; DOI: 10.1038/s41572-020-00232-7).

03

Biological functions

RNA sequestrationSplicing regulationRNA-protein interaction
04

Disease associations

Myotonic dystrophy type 1 (DM1)
05

Safety considerations

Off-target binding to other CUG-repeat transcriptsDelivery to skeletal and cardiac muscle and the central nervous systemPotential loss of wild-type DMPK functionImmune response to oligonucleotide therapeutics
06

Interacting drugs

Delpacibart zotadirsen (AOC 1001)

2 more in the full profile.

07

Biomarkers

MBNL1-regulated alternative splicing (e.g., INSR, CLCN1) (JCI, 2018; DOI: 10.1172/JCI123854)DMPK mRNA levelsNuclear foci count

Beyond the preview

Go deeper on Myotonic dystrophy protein kinase 3' untranslated region CUG-repeat RNA foci (DMPK CUG-repeat RNA foci) (DMPK CUG-repeat RNA foci).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myotonic dystrophy protein kinase 3' untranslated region CUG-repeat RNA foci (DMPK CUG-repeat RNA foci) (DMPK CUG-repeat RNA foci).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call